Filing Details
- Accession Number:
- 0001140361-23-036060
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-25 16:28:06
- Reporting Period:
- 2023-07-21
- Accepted Time:
- 2023-07-25 16:28:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1715768 | Transphorm Inc. | TGAN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1081714 | R Henry Kravis | 30 Hudson Yards New York NY 10001 | No | No | No | No | |
1081715 | R George Roberts | 2800 Sand Hill Road, Suite 200 Menlo Park CA 94025 | No | No | No | No | |
1404912 | Kkr & Co. Inc. | 30 Hudson Yards New York NY 10001 | No | No | No | No | |
1472694 | Llp Management Kkr | 30 Hudson Yards New York NY 10001 | No | No | No | No | |
1472698 | L.p. Partnership Group Kkr | 30 Hudson Yards New York NY 10001 | No | No | No | No | |
1743754 | Kkr Group Holdings Corp. | 30 Hudson Yards New York NY 10001 | No | No | No | No | |
1806548 | L.p. Investors Phorm Kkr | 30 Hudson Yards New York NY 10001 | No | No | No | No | |
1806572 | Kkr Phorm Investors Gp Llc | 30 Hudson Yards New York NY 10001 | No | No | No | No | |
1932162 | Kkr Group Co. Inc. | 30 Hudson Yards New York NY 10001 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-07-21 | 1,735,988 | $3.30 | 24,411,968 | No | 4 | P | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnotes |
Footnotes
- Shares of common stock, $0.0001 par value (the "Common Stock") of Transphorm, Inc. (the "Issuer") issued pursuant to a pro rata subscription rights offering (the "Rights Offering"), which entitled all holders of Common Stock to purchase 0.07655623 of a share of the Issuer's Common Stock, for every share of Common Stock held at a subscription price of $3.30 per whole share. The Rights Offering closed on July 21, 2023.
- The securities reported herein are held by KKR Phorm Investors L.P. KKR Phorm Investors GP LLC is the general partner of KKR Phorm Investors L.P., KKR Group Partnership L.P. is the sole member of KKR Phorm Investors GP LLC, KKR Group Holdings Corp. is the general partner of KKR Group Partnership L.P., KKR Group Co. Inc. is the sole shareholder of KKR Group Holdings Corp., KKR & Co. Inc. is the sole shareholder of KKR Group Co. Inc., KKR Management LLP is the Series I preferred stockholder of KKR & Co. Inc., and Messrs. Henry R. Kravis and George R. Roberts are the founding partners of KKR Management LLP.
- Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.